Search details
1.
Real-world experience with caplacizumab in the management of acute TTP.
Blood
; 137(13): 1731-1740, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33150355
2.
Von Willebrand factor assays in patients with acquired immune thrombotic thrombocytopenia purpura treated with caplacizumab.
Br J Haematol
; 197(3): 349-358, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35262910
3.
Characterization and treatment of congenital thrombotic thrombocytopenic purpura.
Blood
; 133(15): 1644-1651, 2019 04 11.
Article
in English
| MEDLINE | ID: mdl-30770395
4.
Management dilemmas in acute pulmonary embolism.
Thorax
; 69(2): 174-80, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24343784
5.
Further evidence of the limitations of Activated Partial Thromboplastin Time to monitor Argatroban.
Br J Haematol
; 180(4): 594-597, 2018 02.
Article
in English
| MEDLINE | ID: mdl-27785784
6.
Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A.
Haematologica
; 98(12): 1980-7, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23812942
7.
Is fresh frozen plasma as good as prothrombin complex concentrate for vitamin K antagonist reversal in acute intracerebral hemorrhage?
Ann Neurol
; 79(2): 331-2, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26583878
8.
Laboratory methods for monitoring argatroban in heparin-induced thrombocytopenia.
Int J Lab Hematol
; 44(2): 399-406, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34755452
9.
The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals.
Br J Haematol
; 148(1): 15-25, 2010 Jan.
Article
in English
| MEDLINE | ID: mdl-19775301
10.
Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.
J Thromb Thrombolysis
; 29(2): 171-81, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-19882303
11.
Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A.
Thromb Res
; 123(6): 895-901, 2009 Apr.
Article
in English
| MEDLINE | ID: mdl-19012951
12.
Normal prothrombin time in the presence of therapeutic levels of rivaroxaban.
Br J Haematol
; 160(6): 859-61, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23278675
13.
Guideline on the management of bleeding in patients on antithrombotic agents.
Br J Haematol
; 160(1): 35-46, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23116425
14.
Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
Thromb Haemost
; 100(2): 350-5, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18690358
15.
Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.
Blood Coagul Fibrinolysis
; 19(3): 183-9, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18388496
16.
Protein C deficiency screening using a thrombin generation assay - an upgrade.
Thromb Haemost
; 98(3): 691-2, 2007 Sep.
Article
in English
| MEDLINE | ID: mdl-17849065
17.
Why is it so difficult to show that prothrombin complex concentrates are superior to fresh-frozen plasma for warfarin reversal?
Blood Transfus
; 15(3): 277-278, 2017 05.
Article
in English
| MEDLINE | ID: mdl-27416569
18.
Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant.
Thromb Res
; 143: 137-40, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27244105
19.
Protamine reversal of low molecular weight heparin: clinically effective?
Blood Coagul Fibrinolysis
; 22(7): 565-70, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21959588
20.
Management of acute pulmonary embolism.
Br J Hosp Med (Lond)
; 76(10): C150-5, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26457952